1989
DOI: 10.1016/0014-2999(89)90195-7
|View full text |Cite
|
Sign up to set email alerts
|

M2 muscarinic receptors on the iris sphincter muscle differ from those on iris noradrenergic nerves

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
13
1
3

Year Published

1992
1992
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(18 citation statements)
references
References 28 publications
1
13
1
3
Order By: Relevance
“…The present study revealed that the ACh-induced inhibition of the pressor response to adrenergic nerve stimulation was not altered by the addition of pirenzepine at 10-g M, a concentration sufficient to selectively inhibit M1 receptor subtype (16,20) or by 10-9 M 4-DAMP, which is enough to selectively block M3 subtype (21-23). It has been reported that pA2 values for AF-DX 116 at M2 receptors range from 6.8 to 7.4 (6,11,12). The present study demonstrated that the inhibition by ACh of the pressor response to adrenergic nerve stimulation was significantly reversed by AF-DX 116 in concentrations of 10-~ M or higher, suggesting that the prejunctional muscarinic receptor subtype involved is M2.…”
Section: Discussionsupporting
confidence: 58%
See 1 more Smart Citation
“…The present study revealed that the ACh-induced inhibition of the pressor response to adrenergic nerve stimulation was not altered by the addition of pirenzepine at 10-g M, a concentration sufficient to selectively inhibit M1 receptor subtype (16,20) or by 10-9 M 4-DAMP, which is enough to selectively block M3 subtype (21-23). It has been reported that pA2 values for AF-DX 116 at M2 receptors range from 6.8 to 7.4 (6,11,12). The present study demonstrated that the inhibition by ACh of the pressor response to adrenergic nerve stimulation was significantly reversed by AF-DX 116 in concentrations of 10-~ M or higher, suggesting that the prejunctional muscarinic receptor subtype involved is M2.…”
Section: Discussionsupporting
confidence: 58%
“…Modulatory prejunctional muscarinic receptors are present on neurons liberating various neurotransmitters, and there is evidence that the subtypes of muscarinic receptors involved at these sites are not identical for all neurons. The prejunctional muscarinic inhibitory heteroreceptors present on sympathetic nerves in different tissues also vary as to their subtype; those in the heart (9-11) and rabbit iris (12) appear to be muscarine M2 receptors, whereas those in the rabbit vas deferens are of the M1 subtype (13). Nevertheless, little is known about the subtype of these receptors present on adrenergic nerve endings modulating norepinephrine release in dog mesenteric arteries.…”
mentioning
confidence: 96%
“…It has been demonstrated that the activation of these receptors inhibits the activity of adenylyl cyclase via the activation of an inhibitory GTPbinding protein (Gi) [4]. Furthermore, M2 muscarinic receptors have been identified in rabbit and human iris [1,3,6]. Assuming that low tonic release of ACh results in continuous activation of the Gi-adenylyl cyclase pathway, blocking the M2/M4 receptors with atropine or IPB would abolish the inhibition of adenylyl cyclase and result in greater accumulation of cAMP in response to lower doses of β-adrenergic agonists.…”
Section: Discussionmentioning
confidence: 99%
“…The muscarinic receptor subtype predominant in iris sphincter muscles of the guinea-pig (Bognar et al, 1990) and the rabbit has been pharmacologically characterized as the M3 type by use of antagonists, whereas the presynaptic muscarinic receptors involved in autoinhibition of ACh release from nerve endings are the M2 type (Bognar et al, 1989). The finding that pilocarpine and McN-A-343, which do not activate phospholipase C (Leiber et at., 1990;Eglen et al, 1993), did not elicit contraction in sphincter muscles or in dilator muscles suggests that the receptor subtype mediating contraction may be common in dilator and sphincter muscles of the rat.…”
Section: Discussionmentioning
confidence: 99%